[{"source":"The trials offer little useful data to the clinician hoping to treat psychosis-related polydipsia with drugs, except that further evaluative studies need to be conducted in this area. Treatment of any sort for psychosis related polydipsia might only be informative within a well designed, conducted and reported randomised study. The two pioneering studies suggest that larger trials, though difficult, would not be impossible with adequate support and co-ordination.","target":"Output 1: The provided articles suggest that atypical antipsychotic drugs, such as olanzapine and quetiapine, may be effective in reducing psychosis and agitation, although there is a risk of extrapyramidal signs. One study investigates the use of ethyl-eicosapentaenoic acid (E-EPA) as an augmentation to antipsychotics in first-episode psychosis. However, there is no direct evidence specifically addressing polydipsia in the context of psychosis. The evidence presented in the articles is strong enough to support the use of atypical antipsychotics in the treatment of psychosis, but more studies are needed to determine their effect on polydipsia.\n\nOutput 2: There is limited evidence from a single double-blind, placebo-controlled trial investigating demeclocycline treatment for polydipsia in chronically psychotic patients. The study reported a significant reduction in polydipsia and serum sodium levels in the demeclocycline group compared to placebo. However, the sample size was small, and the study did not assess other potential side effects or long-term efficacy. Therefore, more studies are needed to validate the effectiveness and safety of demeclocycline for treating polydipsia in psychosis.\n\nOutput 3: The provided articles do not directly address pharmacological treatments for psychosis-related polydipsia. The first article investigates the use of ethyl-eicosapentaenoic acid (E-EPA) as an adjunct to antipsychotic medications in first-episode psychosis, but no mention of polydipsia is made. The second article conducts a double-blind, placebo-controlled trial of demeclocycline treatment for polydipsia in chronically psychotic patients, reporting significant reductions in polydipsia and hyponatremia. The evidence from this single study is strong enough to suggest that demeclocycline may be an effective intervention for psychosis-related polydipsia. However, more studies are needed to validate these findings and explore other potential pharmacological treatments."},{"source":"The limited evidence suggests that home management is cost effective and preferred by patients. Further large trials comparing these treatments are unlikely to occur. Therefore, home treatment is likely to become the norm; further research will be directed to resolving practical issues.","target":"Output 1: The evidence from the provided articles suggests that home treatment using low-molecular-weight heparins is an effective, safe, and cost-saving strategy for patients with proximal deep vein thrombosis and no symptoms of pulmonary embolism or increased risk of major bleeding. However, more studies are needed to assess the long-term outcomes and potential benefits of home treatment, such as the incidence of post-thrombotic syndrome and leg ulcers. The studies comparing systemic thrombolytic therapy with conventional heparin\/anticoagulation therapy show that thrombolysis achieves better short- and long-term clinical outcomes but at the expense of increased major bleeding and pulmonary emboli. Therefore, systemic thrombolysis should be used selectively in limb-threatening thrombotic situations. Overall, the evidence supports the use of home treatment with low-molecular-weight heparins as a viable option for managing deep vein thrombosis.\n\nOutput 2: The evidence suggests that home treatment using low-molecular-weight heparin (LMWH) is effective, safe, and cost-saving for patients with proximal deep vein thrombosis and no symptoms of pulmonary embolism or increased risk of major bleeding. Several studies, including the Vascular Midi-Pyrenees study and a trial of ardeparin, have shown that LMWH can be administered effectively and safely at home, reducing the duration of hospitalization and improving patient satisfaction. However, more studies are needed to confirm these findings and to evaluate the long-term outcomes of home treatment compared to in-patient care.\n\nOutput 3: The evidence suggests that home treatment using low-molecular-weight heparin is effective, safe, and cost-saving for patients with proximal deep vein thrombosis who have no symptoms of pulmonary embolism or increased risk of major bleeding. Several studies have shown equivalent clinical outcomes between home and in-patient treatment, with the added benefit of decreased hospitalization costs and improved patient satisfaction. However, more studies are needed to establish the efficacy and safety of anticoagulant treatment for superficial vein thrombosis in the outpatient setting."},{"source":"The overall analysis shows a benefit in pulmonary outcomes in the group electively ventilated with HFJV. Of concern is the significant increase in acute brain injury in one trial which used lower mean airway pressures when ventilating with HFJV. There are as yet no long term pulmonary or neurodevelopmental outcomes from any of the trials.","target":"Output 1: The evidence from the provided articles suggests that high-frequency jet ventilation (HFJV) in preterm infants with respiratory distress syndrome does not significantly reduce neonatal mortality or pulmonary morbidity compared to conventional ventilation. In fact, some studies report more adverse outcomes with HFJV. However, there is ongoing debate about the optimal ventilation strategy for very premature infants, and further studies are needed to determine if specific HFJV strategies, such as high-frequency oscillatory ventilation, may offer benefits over conventional ventilation. Overall, the current evidence is not strong enough to justify the widespread use of elective HFJV over conventional ventilation for respiratory distress syndrome in preterm infants.\n\nOutput 2: The evidence from the provided articles suggests that high-frequency jet ventilation (HFJV) in the early management of respiratory distress syndrome in preterm infants results in more adverse outcomes than conventional ventilation. One study did not find a significant difference in mortality or morbidity rates between HFJV and conventional ventilation. Another study found that volume controlled ventilation was both safe and effective in reducing the incidence of intraventricular hemorrhages and abnormal periventricular echodensities. Overall, the evidence is not strong enough to justify the use of elective HFJV over conventional ventilation for respiratory distress syndrome in preterm infants. More studies are needed to validate the findings and determine the optimal mode of ventilatory support for this population.\n\nOutput 3: The provided articles suggest that high-frequency jet ventilation (HFJV) and conventional ventilation (CV) have different effects on preterm infants with respiratory distress syndrome. HFJV has been shown to reduce the incidence of bronchopulmonary dysplasia (BPD) and the need for home oxygen compared to CV. However, HFJV does not prevent acute airleaks and may increase the risk of severe intraventricular hemorrhage and periventricular leukomalacia, especially when using a high-frequency, low-pressure strategy. Early use of HFJV does not prevent or substantially reduce mortality or morbidity rates associated with assisted ventilation. The evidence is strong enough to support the use of HFJV in reducing the incidence of BPD and the need for home oxygen, but more studies are needed to further evaluate its safety and efficacy, particularly in relation to neuroimaging abnormalities."},{"source":"No effect was shown for specific outcomes: laboratory-proven influenza, pneumonia and death from pneumonia. An effect was shown for the non-specific outcomes of ILI, GP consultations for ILI and all-cause mortality in individuals \u2265 60. These non-specific outcomes are difficult to interpret because ILI includes many pathogens, and winter influenza contributes < 10% to all-cause mortality in individuals \u2265 60. The key interest is preventing laboratory-proven influenza in individuals \u2265 60, pneumonia and deaths from pneumonia, and we cannot draw such conclusions.\nThe identified studies are at high risk of bias.\nSome HCWs remain unvaccinated because they do not perceive risk, doubt vaccine efficacy and are concerned about side effects. This review did not find information on co-interventions with HCW vaccination: hand washing, face masks, early detection of laboratory-proven influenza, quarantine, avoiding admissions, anti-virals, and asking HCWs with ILI not to work. We conclude there is no evidence that vaccinating HCWs prevents influenza in elderly residents in LTCFs. High quality RCTs are required to avoid risks of bias in methodology and conduct, and to test these interventions in combination.","target":"Output 1: The evidence from the provided studies suggests that influenza vaccination of healthcare workers in long-term care hospitals reduces the mortality of elderly patients. The average effectiveness of the intervention is supported by significant reductions in total patient mortality and influenza-like illness in hospitals where healthcare workers were vaccinated. However, vaccination of frail elderly long-term-care patients may not provide clinically worthwhile benefits. The evidence is strong enough to justify the conclusion, but more studies may be needed to validate the effectiveness in different populations and settings.\n\nOutput 2: The evidence suggests that influenza vaccination of healthcare workers in long-term care hospitals reduces the mortality of elderly patients on average. Several studies have shown that vaccination of healthcare workers is associated with decreased hospitalizations for cardiac disease, stroke, and pneumonia or influenza in the elderly population. Vaccination programs have been found to be cost-effective and have saved medical care costs by preventing pneumonia and influenza. The evidence is strong enough to justify the conclusion that influenza vaccination for healthcare workers who work with the elderly is effective in reducing serious outcomes and mortality. However, more studies may be needed to validate the exact magnitude of the effect and to investigate the benefits in non-institutionalized elderly populations.\n\nOutput 3: The evidence from multiple studies suggests that influenza vaccination of healthcare workers in long-term care settings reduces mortality among elderly patients (OR: 0.56-0.58, 95% CI: 0.40-0.80). Vaccination of healthcare workers was also associated with a decrease in influenza-like illness (OR: 0.57, 95% CI: 0.34-0.94). The evidence is strong enough to support the recommendation for influenza vaccination of healthcare workers in long-term care settings to protect elderly patients. However, vaccination of frail elderly long-term-care patients may not provide clinically worthwhile benefits."},{"source":"There is some evidence for use of botulinum toxin injections to salivary glands for the treatment of sialorrhea in MND. Further research is required on this important symptom. Data are needed on the problem of sialorrhea in MND and its measurement, both by patient self report measures and objective tests. These will allow the development of better randomized controlled trials.","target":"Output 1: Several studies have investigated treatments for sialorrhea in people with motor neuron disease or amyotrophic lateral sclerosis, including botulinum toxin type B, riluzole, clonidine, glycopyrrolate, and celecoxib. The evidence suggests that botulinum toxin type B and glycopyrrolate are effective in reducing excessive saliva production. Riluzole may have a neuroprotective effect and improve survival in some patients, but its primary indication is for treating amyotrophic lateral sclerosis itself. Clonidine and celecoxib have shown mixed results, with some studies reporting benefits and others not. Overall, the evidence is strong enough to support the use of botulinum toxin type B and glycopyrrolate for managing sialorrhea in people with motor neuron disease or amyotrophic lateral sclerosis. However, more studies are needed to validate the use of other interventions, such as riluzole, clonidine, and celecoxib, for this indication.\n\nOutput 2: Several studies have investigated treatments for sialorrhea in people with motor neuron disease or amyotrophic lateral sclerosis, including clonidine, riluzole, botulinum toxin, glycopyrrolate, and xaliproden. The evidence suggests that these interventions can be effective in reducing salivary secretion and improving symptoms. However, the strength of the evidence varies between studies, with some showing significant improvements and others lacking statistical significance. More studies are needed to validate the effectiveness and optimize the use of these treatments for sialorrhea in people with motor neuron disease or amyotrophic lateral sclerosis.\n\nOutput 3: The evidence suggests that botulinum toxin type B injections and clonidine are effective treatments for sialorrhea in people with motor neuron disease or amyotrophic lateral sclerosis. The studies show significant improvement in patients receiving these interventions compared to placebo. However, more studies are needed to confirm these findings and to evaluate the long-term safety and efficacy of these treatments. Riluzole, an antiglutamate agent, has also shown promise in slowing disease progression in ALS, but its effect on sialorrhea is less clear and requires further investigation."},{"source":"Caring for people in acute day hospitals is as effective as inpatient care in treating acutely ill psychiatric patients. However, further data are still needed on the cost effectiveness of day hospitals.","target":"Output 1: The evidence from the provided articles suggests that day hospitals are effective for treating acutely ill psychiatric patients, leading to less burden on carers in the long term. However, the cost savings for day hospital treatment may be offset by additional costs borne by carers. The studies show mixed results regarding rehospitalization rates, symptomatology, mood, community, and vocational adjustment. While some studies indicate day hospital patients are more involved in work and training activities, others find no significant differences. The evidence is strong enough to support the use of day hospitals as a viable alternative to inpatient treatment for some patients, but more research is needed to establish the specific patient population most suited for this intervention.\n\nOutput 2: The evidence suggests that day hospitals can be effective for treating acutely ill psychiatric patients, leading to less burden on carers in the long term. Studies have shown that day hospital treatment can be as effective as inpatient care in terms of psychopathologic symptoms, treatment satisfaction, and quality of life. Day hospitalization has also been shown to reduce hospital readmissions and total hospital days when combined with intensive treatment and sustained outpatient commitment, particularly for individuals with psychotic disorders. However, more large-scale studies are needed to validate these findings and establish the applicability of day hospital care across various mental health care systems.\n\nOutput 3: The evidence from multiple studies suggests that day hospitals are as effective as inpatient care in treating acute psychiatric disorders in terms of clinical outcomes, such as psychopathology and treatment satisfaction. However, day hospitals may offer additional benefits, such as improved social functioning and longer-term reductions in burden on carers. The cost-effectiveness of day hospitals is also favorable, with lower direct costs to hospitals and potentially higher indirect costs to carers. Overall, the evidence is strong enough to support the use of day hospitals as a viable alternative to inpatient care for some acutely ill psychiatric patients. However, more research is needed to determine which patients are most suitable for day hospital treatment and to further evaluate its long-term effectiveness and cost-effectiveness."},{"source":"Both small trials had significant risks of bias and do not provide reliable evidence on the effects of surgery for cervical spondylotic radiculopathy or myelopathy. It is unclear whether the short-term risks of surgery are offset by long-term benefits. Further research is very likely to have an impact on the estimate of effect and our confidence in it.\nThere is low quality evidence that surgery may provide pain relief faster than physiotherapy or hard collar immobilization in patients with cervical radiculopathy; but there is little or no difference in the long-term.\nThere is very low quality evidence that patients with mild myelopathy feel subjectively better shortly after surgery, but there is little or no difference in the long-term.","target":"Output 1: The provided articles suggest that various surgical interventions, such as anterior cervical discectomy and fusion with interbody implants, allografts, or disc arthroplasty, have shown positive outcomes in treating cervical radiculomyelopathy. However, the evidence strength varies. For instance, the study comparing cervical disc arthroplasty with allograft fusion provides strong evidence of improved neurological success, reduced secondary revision surgeries, and lower rate of adjacent-segment reoperation. In contrast, the article on anterior cervical fusion with tantalum implant shows similar clinical and radiologic outcomes for both treatments without significant differences. Overall, the evidence suggests that surgery can be effective in managing cervical radiculomyelopathy, but more studies are needed to validate the specific intervention's superiority and long-term outcomes.\n\nOutput 2: The evidence from the provided articles suggests that surgical interventions, including anterior cervical discectomy and fusion, interbody fusion with beta-TCP, and arthroplasty, can be effective in treating cervical radiculomyelopathy. However, the need for interbody fusion after discectomy remains controversial. The studies generally show significant improvements in clinical outcomes, but more research is needed to establish definitive conclusions and to compare the effectiveness and safety of different surgical approaches. Additionally, non-surgical interventions such as physiotherapy and collar use may provide relief in the early stages of cervical radiculopathy.\n\nOutput 3: The evidence from the provided articles suggests that surgical interventions, such as anterior cervical discectomy and fusion (ACDF), cervical total disc replacement (CTDR), and spinal cord stimulation (SCS), can be effective in treating cervical radiculomyelopathy. However, the specific effectiveness of each intervention varies. For instance, CTDR has shown promising results in preserving motion at the treated level compared to ACDF. SCS has been shown to provide lasting relief for some patients with chronic cervical zygapophyseal-joint pain. However, more studies are needed to validate these findings and to compare the effectiveness and safety of different surgical interventions for cervical radiculomyelopathy. Overall, the evidence is strong enough to suggest that surgery can be an effective option for treating cervical radiculomyelopathy, but the choice of intervention depends on individual patient factors and surgeon expertise."},{"source":"The available evidence indicates some beneficial effects with second-generation antipsychotics, mood stabilisers, and dietary supplementation by omega-3 fatty acids. However, these are mostly based on single study effect estimates. Antidepressants are not widely supported for BPD treatment, but may be helpful in the presence of comorbid conditions. Total BPD severity was not significantly influenced by any drug. No promising results are available for the core BPD symptoms of chronic feelings of emptiness, identity disturbance and abandonment. Conclusions have to be drawn carefully in the light of several limitations of the RCT evidence that constrain applicability to everyday clinical settings (among others, patients' characteristics and duration of interventions and observation periods).","target":"Output 1: The evidence from the provided articles suggests that there is no clear first-choice pharmacological treatment for borderline personality disorder. Carbamazepine, olanzapine, divalproex sodium, fluvoxamine, and aripiprazole have all been investigated with inconclusive results. A combined psychotherapeutic and pharmacological approach appears to be effective, as shown in studies using dialectical behavior therapy. Overall, more robust and larger-scale studies are needed to definitively determine the efficacy of pharmacological interventions for people with borderline personality disorder.\n\nOutput 2: The evidence suggests that there is no first-choice pharmacological treatment for borderline personality disorder (BPD), and combined psychotherapeutic and pharmacological approaches are effective in reducing dropout rates. Atypical antipsychotics, such as aripiprazole, have shown promise in treating symptoms of BPD, but more studies are needed to confirm their efficacy. Selective serotonin reuptake inhibitors (SSRIs) may be helpful for affect lability, impulsivity, and aggression. However, a randomized, placebo-controlled SSRI study provided inconclusive results. Anticonvulsant agents, such as divalproex sodium, may also be beneficial for some symptoms of BPD. Overall, the evidence is not yet strong enough to definitively conclude the average effectiveness of pharmacological interventions for BPD, and more studies are needed to validate these findings.\n\nOutput 3: The evidence from the provided articles suggests that a combined approach of psychotherapy and pharmacological interventions can be effective for people with borderline personality disorder. Olanzapine showed significant improvement over placebo in depression, anxiety, and impulsivity\/aggressive behavior in one study, while fluvoxamine improved rapid mood shifts in female patients. Divalproex sodium and carbamazepine showed no significant positive effects. Omega-3 fatty acids may be effective for women with moderately severe borderline personality disorder. However, more studies are needed to confirm these findings and determine the most effective pharmacological interventions for this population."},{"source":"The results indicate that exercise has positive short-term effects on self-esteem in children and young people. Since there are no known negative effects of exercise and many positive effects on physical health, exercise may be an important measure in improving children's self-esteem. These conclusions are based on several small low-quality trials.","target":"Output 1: The evidence from the provided articles suggests that aerobic exercise programs can improve self-esteem in children and young people. For instance, one study found significant increases in self-esteem following an 8-week aerobic exercise intervention in preschoolers. Another study reported improvements in self-esteem in pre-adolescent and adolescent females after participating in a physical activity intervention package. However, the evidence is not entirely conclusive, as some studies showed limited benefits or age-related differences in self-esteem improvements. More research is needed to validate the average effectiveness and potential modifying factors of exercise interventions on self-esteem in children and young people.\n\nOutput 2: The evidence from the provided articles suggests that exercise interventions, including aerobic and athletic programs, can improve self-esteem in children and young people, particularly those with low physical self-esteem. The studies show significant improvements in self-esteem measures, as well as other benefits such as improved fitness, body satisfaction, and mental health status. The evidence is strong enough to support the conclusion that exercise is an effective way to improve self-esteem in children and young people, but more studies are needed to validate the findings and explore the long-term effects of different types of exercise programs.\n\nOutput 3: The evidence from the provided articles suggests that exercise interventions, including aerobic exercise and physical activity programs, can improve self-esteem in children and young people, particularly in specific populations such as breast cancer survivors and obese adolescents. However, the strength of the evidence varies, with some studies showing significant improvements and others showing no effect. More studies are needed to validate and expand upon these findings, particularly in larger and more diverse populations. Overall, the evidence supports the potential benefits of exercise for improving self-esteem in children and young people."},{"source":"There is currently no evidence of the effects of extraction of primary canine teeth in 10-13 year old children with one or two palatally displaced permanent canine teeth.","target":"Output 1: The evidence from the provided articles suggests that extracting primary canines as an interceptive measure for palatally displaced permanent canines has a moderate success rate of around 65%. However, the effectiveness of extracting deciduous canines alone is not significantly greater than that of untreated controls. The use of a headgear in addition to extraction shows a higher success rate of 80%. The evidence is strong enough to support the use of these interventions, but more studies may be needed to confirm their long-term effectiveness and potential side effects.\n\nOutput 2: The provided articles suggest that extracting primary canines alone or in combination with a headgear can be effective interceptive approaches for palatally displaced permanent canines in children. The success rates range from 65.2% to 87.5%, with the addition of a headgear leading to a greater improvement in intraosseous canine position. However, more studies may be needed to validate these findings and establish the optimal approach, as the evidence presented in the articles is not conclusive. The use of a transpalatal arch for correcting unilateral first molar crossbites and fissure sealing of permanent first molars were also discussed in the articles, but they are not directly related to the query.\n\nOutput 3: The provided articles suggest that the extraction of primary canines, either alone or in combination with headgear use, can be effective in intercepting palatal displacement of permanent canines in children. The success rates range from 50% to 87.5%, with the addition of headgear resulting in significantly improved intraosseous canine position. However, more studies may be needed to validate these findings and establish the optimal intervention and timing for extracting primary teeth to address palatally displaced permanent canines."},{"source":"Methenamine hippurate may be effective for preventing UTI in patients without renal tract abnormalities, particularly when used for short-term prophylaxis. It does not appear to work in patients with neuropathic bladder or in patients who have renal tract abnormalities. The rate of adverse events was low, but poorly described.\nThere is a need for further large well-conducted RCTs to clarify this question, particularly for longer term use for people without neuropathic bladder.","target":"Output 1: Methenamine hippurate (MH) has been investigated for its preventive effect on urinary tract infections (UTIs) in various clinical settings, including gynecological surgery and spinal cord injury patients. The evidence suggests that MH can reduce the incidence of bacteriuria and UTIs, particularly in gynecological surgery patients with short-term catheterization. However, the evidence is not conclusive, as some studies have reported no significant difference between MH and placebo groups. Moreover, the effectiveness of MH in preventing UTIs in spinal cord injury patients is questionable, as a large randomized controlled trial found no benefit in adding MH or cranberry tablets to the usual regimen. Overall, while MH shows some promise in preventing UTIs, particularly in specific populations and situations, more studies are needed to validate its effectiveness and establish optimal dosing and administration.\n\nOutput 2: Methenamine hippurate has been shown to reduce the incidence of postoperative bacteriuria and urinary tract infections in various patient populations, including those with neuropathic bladder following spinal cord injury and women undergoing gynecologic surgery. In clinical trials, the use of methenamine hippurate resulted in a significant decrease in the number of urinary tract infections compared to placebo or no treatment. The evidence is strong enough to support the conclusion that methenamine hippurate is an effective intervention for preventing urinary tract inctions. However, more studies may be needed to determine the optimal dosing and duration of treatment, as well as its effectiveness in specific patient populations and settings.\n\nOutput 3: Methenamine hippurate (MH) has been shown to reduce the incidence of postoperative bacteriuria and urinary tract infections (UTI) in various patient populations, including those with neuropathic bladder following spinal cord injury (SCI) and women undergoing gynecologic surgery. Several studies have compared MH to other antibiotics, such as trimethoprim, nitrofurantoin, and placebo. The evidence suggests that MH is effective in preventing UTIs, with lower incidence rates compared to placebo and comparable or even better tolerability than some antibiotics. However, more studies are needed to confirm these findings and to establish the optimal dosing and duration of MH prophylaxis."},{"source":"In order to eliminate potential selection bias, more RCTs need to be conducted in this area so that effectiveness, as well as efficacy, can be ascertained. The interlock programme appears to be effective while the device is installed in the vehicle of the offender. Studies need to address ways of improving recidivism rates in the long term, as the major challenges are participation rates, compliance and durability.","target":"Output 1: The evidence from the studies suggests that alcohol ignition interlock programs effectively reduce drink driving recidivism while the interlock is installed. However, because only a small percentage of offenders choose to participate, the overall impact on the recidivism rate of all offenders is limited. The studies provide strong evidence for the effectiveness of interlocks, but more research is needed to increase participation rates and ensure lasting reductions in recidivism.\n\nOutput 2: The evidence from the provided articles suggests that alcohol ignition interlock programs effectively reduce drink driving recidivism while the restriction is in place, with an average reduction in alcohol traffic violations ranging from 3.3% to 65%. However, more studies are needed to evaluate the long-term effectiveness and the overall impact on DUI offenders, as only a small portion of eligible drivers typically participate in these programs.\n\nOutput 3: The evidence from controlled studies suggests that alcohol ignition interlocks effectively reduce impaired driving recidivism while the device is in use. However, the practical effectiveness is limited due to low participation rates among offenders. A study of a court policy that mandated interlock use showed substantial reductions in DUI recidivism compared to similar courts without interlocks. Overall, the evidence is strong enough to support the conclusion that ignition interlock programs can reduce drink driving recidivism, but more studies are needed to assess their long-term impact and effectiveness in increasing participation rates."},{"source":"There is not enough evidence to evaluate the use of nutrient therapy for suspected impaired fetal growth. The studies were too small to assess clinical outcomes adequately.","target":"Output 1: The evidence from the provided articles suggests that maternal nutrient supplementation, including iron, folic acid, multiple micronutrients, and calcium, can have positive effects on fetal growth and development. However, the results are not consistent across all studies, and some show no significant improvement or even potential harm. The evidence is strongest for the benefits of iron and folic acid supplementation on fetal growth and reducing fetal loss and infant mortality, especially in undernourished and anemic women. The evidence for other micronutrients and calcium supplementation is less clear, and more studies are needed to validate their effects on fetal growth and development. Overall, maternal nutrient supplementation can be a valuable intervention for improving fetal growth and development, but the specific nutrients and dosages required need further investigation.\n\nOutput 2: The evidence suggests that maternal nutrient supplementation, particularly with multiple micronutrients, can support fetal growth and bone mineral content in preterm infants. However, the impact on fetal loss and infant mortality is unclear, with some studies showing no effect and others reporting potential benefits. Overall, the evidence is strong enough to support the use of maternal nutrient supplementation for suspected impaired fetal growth, but more studies are needed to fully understand its effects and optimal composition.\n\nOutput 3: The evidence from the provided articles suggests that maternal micronutrient supplementation, including iron and folic acid, zinc, and multiple micronutrients, can improve maternal nutrient status and reduce the risk of anemia and iron deficiency during pregnancy. However, the impact on fetal growth and birth outcomes is inconsistent. Some studies show no significant effect on fetal growth or birth weight, while others suggest a positive impact. The evidence on the effect of maternal micronutrient supplementation on fetal loss and infant mortality is also mixed. Overall, more studies are needed to establish the effectiveness and optimal composition of maternal micronutrient supplements for suspected impaired fetal growth."},{"source":"Research in this field is limited. Personal assistance is expensive and difficult to organise, especially in places that do not already have services in place, but its total cost relative to other services is unknown. When implementing new programmes, recipients could be randomly assigned to different forms of assistance (e.g. organised by individual users versus organised through a cooperative). While advocates may support personal assistance for myriad reasons, this review demonstrates that further studies are required to determine which models of assistance are most effective and efficient for particular people.","target":"Output 1: The articles provide evidence on interventions for older adults with physical and cognitive impairments, including exercise programs, nutritional supplements, and home-based interventions. The results suggest improvements in functional abilities, self-efficacy, and adaptive coping, but engagement and adherence to interventions remain challenges. The evidence is strong for the positive effects of multicomponent home interventions on functional difficulties and self-efficacy, but more studies are needed to validate the effectiveness of other interventions, such as pedometer-driven walking programs and cash and counseling models, in this population.\n\nOutput 2: The provided articles describe interventions for older adults with various physical and cognitive impairments. While some studies focus on physical rehabilitation, others investigate nutritional or social interventions. The evidence suggests that these interventions can lead to improvements in functional abilities, mental health, and quality of life. However, the strength of the evidence varies between studies, and more research is needed to establish the average effectiveness of personal assistance for adults (19-64) with both physical and intellectual impairments. The evidence presented in the articles provides a foundation for further investigation but does not yet provide definitive answers.\n\nOutput 3: Based on the provided articles, interventions such as physical therapy, assistive devices, and social cognitive theory-based interventions have shown positive effects on functional ability and health-related quality of life for older adults with physical impairments. However, there is limited evidence specifically for adults with both physical and intellectual impairments. The evidence presented in the articles is strong for the effectiveness of interventions on physical impairments but more studies are needed to validate the effects on intellectual impairments and the combination of both."},{"source":"Studies evaluated in this review report significant improvements in knowledge measures and protective behaviours. Results might have differed had the true ICCs from studies been available or cluster-adjusted results been available. Several studies reported harms, suggesting a need to monitor the impact of similar interventions. Retention of knowledge should be measured beyond 3-12 months. Further investigation of the best forms of presentation and optimal age of programme delivery is required.","target":"Output 1: The articles provide evidence that school-based education programs for the prevention of child sexual abuse can increase children's knowledge and skills related to abuse prevention. However, the gains are often small and may not be maintained over time. Some studies also report positive reactions from parents and children. The evidence is strong enough to suggest that such programs have some effect, but more research is needed to determine their long-term impact and to identify ways to make them more effective.\n\nOutput 2: The evidence from the provided articles suggests that school-based education programs for the prevention of child sexual abuse show statistically significant though small gains in children's knowledge and skills. These programs have been effective in enhancing children's ability to recognize safe and unsafe situations and maintaining these gains over time. However, more studies are needed to validate these findings and to explore ways to present the programs in a more powerful manner to maximize their impact. Overall, the evidence is strong enough to support the use of school-based education programs as a valuable tool in the prevention of child sexual abuse, but continued research is necessary to optimize their effectiveness.\n\nOutput 3: The evidence suggests that school-based education programs for the prevention of child sexual abuse have statistically significant, though small, effects on increasing children's knowledge and skills in abuse prevention. However, the programs may need to be presented in a more powerful manner for greater impact. The studies evaluating these programs generally have strong designs, but more research is needed to establish long-term efficacy and applicability to diverse populations. Overall, school-based education programs can be an important component of a multistrategy approach to preventing child sexual abuse."},{"source":"The potential benefit of antibiotics in the treatment of clinically diagnosed acute rhinosinusitis needs to be seen in the context of a high prevalence of adverse events. Taking into account antibiotic resistance and the very low incidence of serious complications, we conclude that there is no place for antibiotics for the patient with clinically diagnosed, uncomplicated acute rhinosinusitis. This review cannot make recommendations for children, patients with a suppressed immune system and patients with severe disease, as these populations were not included in the available trials.","target":"Output 1: The evidence from the provided articles suggests that antibiotics may offer only modest benefits for adults with clinically diagnosed acute rhinosinusitis, as shown in some studies but not in others. The addition of intranasal corticosteroids to antibiotics may improve clinical success rates and accelerate recovery in patients with a history of chronic rhinitis or recurrent sinusitis. However, the evidence is not conclusive, and more studies are needed to establish the optimal treatment approach for this common condition.\n\nOutput 2: The evidence suggests that antibiotics provide no advantage and may increase adverse effects for adults with clinically diagnosed acute rhinosinusitis. However, the value of antibiotics in this condition is uncertain. Some studies suggest that intranasal corticosteroids or mucolytics, such as MFNS, may be effective adjunctive therapies. However, more studies are needed to establish the efficacy and safety of these interventions and to determine the optimal treatment approach for acute rhinosinusitis in adults.\n\nOutput 3: The evidence regarding the effectiveness of antibiotics for clinically diagnosed acute rhinosinusitis in adults is uncertain. A study evaluating amoxicillin-clavulanate found no advantage for patients and an increased risk of adverse effects. However, intranasal corticosteroids used with antibiotics have shown improvement in rhinosinusitis symptoms compared to antibiotic therapy alone. More studies are needed to establish the efficacy of intranasal corticosteroid monotherapy for acute, uncomplicated rhinosinusitis. Overall, the evidence is not strong enough to definitively conclude that antibiotics improve outcomes for adults with clinically diagnosed acute rhinosinusitis."},{"source":"Overall, there is preliminary evidence that a variety of cognitive-behavioral interventions can be used with children and adolescents to successfully manage or reduce pain and distress associated with needle-related procedures. However, many of the included studies received lower quality scores because they failed to describe the randomization procedure and participant withdrawals or drop-outs from the study. Further RCTs need to be conducted, particularly for the many interventions for which we could not locate any trials.","target":"Output 1: The evidence from the provided articles suggests that psychological interventions, such as cognitive-behavioral therapy (CBT), transcutaneous electrical nerve stimulation (TENS), and distraction techniques, can be effective in reducing needle-related procedural pain and distress in children and adolescents. The studies report significant reductions in pain severity, anxiety, and behavioral distress, as well as fewer absences from school. However, more studies are needed to validate these findings and to address barriers to participation in psychosocial interventions for pediatric pain. Overall, the evidence is strong enough to support the use of psychological interventions as a complementary approach to medical treatments for needle-related procedural pain in children and adolescents.\n\nOutput 2: The articles provide evidence for the effectiveness of various psychological interventions, such as cognitive-behavioral therapy (CBT), distraction techniques, and parental involvement, in reducing needle-related procedural pain and distress in children and adolescents. The studies show significant improvements in pain intensity, behavioral distress, and coping skills. However, more research is needed to establish the average effectiveness and generalizability of these interventions, as well as to determine the optimal intervention for different age groups and medical conditions. The evidence presented in the articles is strong but not definitive, and further studies are necessary to validate and expand upon these findings.\n\nOutput 3: The evidence from the provided articles suggests that psychological interventions, such as cognitive-behavioral therapy, distraction techniques, and family-based interventions, can effectively reduce needle-related procedural pain and distress in children and adolescents. These interventions have shown significant reductions in pain intensity, behavioral distress, and anxiety. However, more studies are needed to validate these findings and determine the most effective intervention for different age groups and medical conditions. The evidence presented in the articles is strong but not definitive, and larger, more rigorous studies are required to establish the efficacy and optimal implementation of these interventions."},{"source":"This review was unable to demonstrate any advantage of CCPT over other airway clearance techniques in terms of respiratory function, but this may have reflected insufficient evidence rather than real equivalence between methods. There was a trend for participants to prefer self-administered airway clearance techniques. Limitations of this review included a paucity of well-designed, adequately-powered, long-term trials.","target":"Output 1: The evidence from the provided articles suggests that conventional chest physiotherapy, including postural drainage, percussion, and the active cycle of breathing techniques (ACBT), is effective in improving lung function and clearing secretions in patients with cystic fibrosis (CF). However, some studies also suggest that alternative methods, such as high-frequency chest wall oscillation (HFCWO) and high-frequency chest compressions (HFCC), may be equally effective or even more effective than conventional physiotherapy. The evidence is generally strong, but more studies are needed to compare the long-term effects and cost-effectiveness of different methods. Overall, conventional chest physiotherapy remains a standard component of CF care, but patients and healthcare providers should be aware of alternative options and their potential benefits.\n\nOutput 2: The evidence suggests that conventional chest physiotherapy, including postural drainage and forced expiratory techniques, is effective in improving lung function and reducing symptoms in cystic fibrosis (CF) patients compared to no regular chest physiotherapy. However, high-frequency chest compression and positive expiratory pressure physiotherapy have also shown promise in enhancing sputum clearance. The studies provide moderate evidence to support the use of these interventions, but more research is needed to establish their long-term benefits and optimal application in CF management.\n\nOutput 3: The evidence from the provided articles suggests that conventional chest physiotherapy, including postural drainage with percussion, remains effective in improving pulmonary function and clearing secretions in cystic fibrosis patients compared to other forms of chest physiotherapy such as high-frequency chest wall oscillation, active cycle of breathing techniques, and positive expiratory pressure techniques. However, some studies indicate that alternative methods like autogenic drainage may be as effective as conventional physiotherapy in clearing mucus and improving ventilation. Overall, the evidence is strong enough to support the continued use of conventional chest physiotherapy as a standard component of therapy in cystic fibrosis, but further studies are needed to compare the long-term effects and patient preferences for different methods."},{"source":"Implications for practice\nNo trials were found addressing treatment of VVC in HIV positive women.In comparison to placebo,Fluconazole was found to be an effective preventative intervention. However, the potential for resistant Candida organisms to develop might impact the feasibility of implementation.\nDirection of findings suggests that Clotrimazole and Lactobacillus improved the prophylactic outcomes when compared to placebo.\nImplications for researchThere is a need to evaluate drugs and drug regimens for VVC treatment and prophylaxis in HIV positive women through randomised clinical trials. Development of resistance to azoles remains under-studied and more work must be done in this area, so as to determine whether routine prophylaxis for VVC is at all needed or whether adequate ART would be sufficient to prevent recurrent VVC. The viral load in vaginal secretions with or without treatment or prophylaxis has not been studied, this is very relevant to the spread of HIV.","target":"Output 1: The evidence suggests that weekly fluconazole prophylaxis is effective in preventing oropharyngeal and vaginal candidiasis in HIV-infected women at risk for recurrent mucosal candidiasis. Clotrimazole and Lactobacillus acidophilus intravaginal applications have also shown some effectiveness in preventing vaginal candidiasis. However, further research is needed to identify barriers to implementing evidence-based practices in community settings for the prevention and treatment of vulvovaginal candidiasis in women with HIV infection. Overall, the evidence is strong enough to support the use of fluconazole prophylaxis in this population, but more studies are needed to validate the effectiveness of other interventions.\n\nOutput 2: The evidence suggests that weekly fluconazole prophylaxis is effective in preventing mucosal candidiasis in HIV-infected women (Borchers et al., 2001). However, more studies are needed to define the optimal regimen for both the treatment and prevention of recurrent oral candidiasis in HIV-infected patients, addressing compliance, cost, and resistance (Borchers et al., 2001; Kau et al., 2000). The studies evaluating self-care approaches to prophylaxis of vulvovaginal candidiasis with Lactobacillus acidophilus or clotrimazole tablets did not provide clear evidence of superiority (Borchers et al., 2002). Overall, the evidence is strong enough to support the use of fluconazole prophylaxis for preventing mucosal candidiasis in HIV-infected women, but more research is needed to optimize the treatment and prevention of oral candidiasis.\n\nOutput 3: The articles provide evidence for two interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection: weekly intravaginal application of clotrimazole tablets and weekly fluconazole prophylaxis. The studies suggest that both interventions are effective in reducing the risk and incidence of vaginal candidiasis, with fluconazole also preventing oropharyngeal candidiasis. The evidence is strong enough to justify the conclusion that these interventions can be effective in preventing and treating vulvovaginal candidiasis in women with HIV infection. However, more studies may be needed to evaluate long-term safety and efficacy, as well as cost-effectiveness."},{"source":"There was evidence individual TFCBT, EMDR, stress management and group TFCBT are effective in the treatment of PTSD. Other non-trauma focused psychological treatments did not reduce PTSD symptoms as significantly. There was some evidence that individual TFCBT and EMDR are superior to stress management in the treatment of PTSD at between 2 and 5 months following treatment, and also that TFCBT, EMDR and stress management were more effective than other therapies. There was insufficient evidence to determine whether psychological treatment is harmful. There was some evidence of greater drop-out in active treatment groups. The considerable unexplained heterogeneity observed in these comparisons, and the potential impact of publication bias on these data, suggest the need for caution in interpreting the results of this review.","target":"Output 1: The evidence suggests that psychological treatments, such as cognitive-behavioral therapy (CBT), prolonged exposure, and eye movement desensitization and reprocessing (EMDR), can effectively reduce symptoms of PTSD in various populations, including adults and children who have experienced different types of trauma. However, more studies are needed to establish the long-term efficacy and optimal treatment approaches for PTSD, particularly for chronic cases and specific populations, such as combat veterans and sexual abuse survivors. The evidence in the provided articles is strong enough to support the conclusion that psychological treatments can be effective for PTSD, but further research is necessary to validate the specific interventions and their applicability to diverse populations.\n\nOutput 2: The articles provide evidence for the effectiveness of various psychological interventions, including cognitive-behavioral therapy (CBT), prolonged exposure, cognitive-processing therapy, eye movement desensitization and reprocessing (EMDR), trauma-focused group therapy, and imaginal exposure with cognitive restructuring, in treating post-traumatic stress disorder (PTSD). The studies show significant improvements in PTSD symptoms immediately after treatment and at follow-ups. However, the duration and extent of these improvements vary between interventions. For instance, CBT and EMDR have shown superior outcomes in some studies compared to other interventions or control groups. Overall, the evidence is strong enough to support the average effectiveness of these interventions in treating PTSD, but more research is needed to determine which intervention is most effective for specific populations and to understand the long-term outcomes.\n\nOutput 3: The evidence from the provided articles suggests that various psychological interventions, including cognitive-behavioral therapy (CBT), eye movement desensitization and reprocessing (EMDR), stress inoculation training (SIT), prolonged exposure (PE), and trauma-focused CBT, have shown effectiveness in reducing PTSD symptoms. However, the specific interventions that are most effective and the optimal treatment duration remain unclear. The evidence is strong enough to support the use of these interventions as viable options for PTSD treatment, but more studies are needed to determine which intervention is most effective for which population and to establish best practices for implementation."},{"source":"Researchers sometimes adopt attention check questions that ask participants to think back to an earlier part of the survey and recall specific information. Read the 'Generated Summaries' section, and follow the instructions exactly.","target":"Select the order for Outputs A, B, C as the following: 3, 2, 1"},{"source":"Researchers sometimes adopt attention check questions that ask participants to think back to an earlier part of the survey and recall specific information. Read the 'Generated Summaries' section, and follow the instructions exactly.","target":"Select the order for Outputs A, B, C as the following: 3, 2, 1"},{"source":"At present, there is insufficient RCT evidence to enable evaluation of the effect of TPD in patients with AKI. Well-designed and larger RCTs are required to better understand the risks and benefits of TPD for AKI.","target":"Output 1: The provided articles suggest that both tidal peritoneal dialysis (TPD) and continuous equilibrating peritoneal dialysis (CEPD) have similar adequacy for treating acute renal failure (ARF), as indicated by solute reduction indices. However, TPD may offer advantages such as lower rates of peritonitis and hospital admission. The evidence is strong but more studies are needed to confirm the superiority of TPD over CEPD and to assess its long-term efficacy and safety.\n\nOutput 2: The provided articles suggest that tidal peritoneal dialysis (TPD) results in higher solute clearances and greater potassium and phosphate clearances compared to continuous equilibrating peritoneal dialysis (CEPD) in mild to moderate hypercatabolic acute renal failure. TPD is also less expensive and less time-consuming. However, TPD results in greater protein loss. CEPD did not meet the dialysis adequacy standard in one study, but both TPD and CEPD are reasonable options for mild-moderate hypercatabolic ARF. The evidence is strong enough to support the conclusion that TPD is an effective intervention for acute renal failure, but more studies are needed to confirm its long-term safety and efficacy.\n\nOutput 3: The provided articles compare the effectiveness of shorter tidal peritoneal dialysis (TPD) with continuous equilibrating peritoneal dialysis (CEPD) in acute renal failure (ARF) using their adequacies as standards. The studies suggest that TPD is as effective as CEPD in terms of patient and technique survival, but TPD is associated with lower rates of peritonitis and dialysis-related hospital admission. However, more studies are needed to validate these findings and establish the superiority of TPD over CEPD in the treatment of ARF."},{"source":"There was evidence from three pooled RCTs that ASA significantly reduces the recurrence of sporadic adenomatous polyps after one to three years. There is evidence from short-term studies to support regression, but not elimination or prevention of CRAs in FAP.","target":"Output 1: The evidence from randomized trials suggests that aspirin and other NSAIDs, such as celecoxib, can reduce the risk of developing colorectal adenomas and possibly carcinomas. Aspirin has been shown to be effective in preventing colorectal adenoma recurrence in patients with previous colorectal cancer. However, NSAIDs can cause gastrointestinal side effects due to COX inhibition. Misoprostol and other protective agents have been used to mitigate these side effects. Overall, the evidence is strong enough to support the use of aspirin and other NSAIDs for colorectal cancer prevention, but more studies are needed to fully understand their risks and benefits.\n\nOutput 2: The evidence from several studies suggests that regular use of aspirin and nonaspirin NSAIDs may decrease the risk of colorectal adenomas and potentially colorectal carcinomas. However, the preventive effect of aspirin is more established, with a relative risk of 0.65 (95% CI: 0.46 to 0.91) for any recurrent adenoma and a hazard ratio for the detection of a new polyp of 0.64 (95% CI: 0.43 to 0.94). The evidence for nonaspirin NSAIDs is less clear, with some studies reporting a protective effect and others not. Overall, the evidence is strong enough to support the use of aspirin for colorectal cancer prevention, but more studies are needed to confirm the role of nonaspirin NSAIDs.\n\nOutput 3: The evidence suggests that daily use of aspirin is effective in reducing the incidence of colorectal adenomas and possibly colorectal carcinomas. However, the available data is not sufficient to serve as a firm recommendation, and more studies are needed to validate these findings. Some studies also indicate that NSAIDs, particularly COX-2 inhibitors, may have chemopreventive effects against colorectal adenomas and carcinomas, but the evidence is not conclusive. Overall, the evidence is moderate, and more well-designed studies are needed to establish the effectiveness and safety of NSAIDs and aspirin for preventing colorectal adenomas and carcinomas."},{"source":"For most \"red flags,\" there is insufficient evidence to provide recommendations regarding their diagnostic accuracy or usefulness for detecting spinal malignancy. The available evidence indicates that in patients with LBP, an indication of spinal malignancy should not be based on the results of one single \"red flag\" question. Further research to evaluate the performance of different combinations of tests is recommended.","target":"Output 1: The articles suggest that the prevalence of malignancy in patients with low-back pain is low, but certain red flags such as age, previous cancer history, long duration of pain, and elevated ESR can increase the likelihood of cancer. Combining historical features and ESR results can help identify cancer while minimizing x-ray utilization. However, the evidence is not strong enough to definitively conclude that these red flags reliably identify all cases of cancer in patients with low-back pain. Further studies are needed to validate the diagnostic accuracy of these red flags in identifying malignancies in this population.\n\nOutput 2: Several studies suggest that the use of red flags to screen for malignancy in patients with low-back pain is important to limit unnecessary imaging and referrals. Eleven clinical criteria have been proposed to identify high-risk patients for spinal pathologies, including malignancy. A retrospective study of 1,975 patients with low-back pain found that only 0.2% had malignancies. The evidence supports the use of red flags as a screening tool to identify high-risk patients for further evaluation, but more studies are needed to validate their sensitivity and specificity. Overall, the evidence suggests that the use of red flags can help reduce unnecessary imaging and referrals while ensuring that serious conditions are not missed.\n\nOutput 3: The articles suggest that certain red flags, such as age over 50, previous cancer history, pain duration over 1 month, and failure to improve with conservative therapy, can help identify patients with low-back pain who may have underlying malignancy. Combining historical features and ESR results can lead to an algorithm that limits x-ray utilization while identifying cancer patients. However, selective criteria for radiography use may not reduce x-ray utilization without further refinement. The evidence is strong enough to support the use of these red flags in identifying potential malignancies, but more studies are needed to validate the specificity and sensitivity of the algorithm."},{"source":"The findings indicate that music during planned caesarean section under regional anaesthesia may improve pulse rate and birth satisfaction score. However, the magnitude of these benefits is small and the methodological quality of the one included trial is questionable. Therefore, the clinical significance of music is unclear. More research is needed to investigate the effects of music during caesarean section under regional anaesthesia on both maternal and infant outcomes, in various ethnic pregnant women, and with adequate sample sizes.","target":"Output 1: The evidence from the provided articles suggests that listening to music during caesarean section under regional anaesthesia may have positive effects on maternal emotional reactions, perceived threat, and physiological responses, such as reduced systolic blood pressure. Additionally, supplementing mothers with oxygen during the procedure does not seem to significantly impact neonatal well-being. However, more studies are needed to establish the definitive effects of music on infant outcomes, such as neurobehavioural status and long-term development. Overall, the evidence is promising but not yet conclusive.\n\nOutput 2: The evidence from the provided articles suggests that listening to music during caesarean section under regional anaesthesia may have positive effects on maternal emotional reactions, cognitive appraisal of threat, and stress-related physiological responses. However, more studies are needed to confirm these findings and assess the impact on infant outcomes. The evidence is not strong enough to definitively conclude that music improves maternal and infant outcomes during caesarean section under regional anaesthesia.\n\nOutput 3: The evidence from the provided articles suggests that listening to music during caesarean section under regional anaesthesia may have positive effects on maternal emotions, physiological reactions, and neonatal neurobehavioural status. However, more studies are needed to establish a definitive conclusion on the effectiveness of this intervention, as the current evidence is not strong enough to justify a firm conclusion. The studies that have been conducted show promising results, but they are limited in size and scope. Future research should focus on larger, more rigorous studies to determine the true impact of music on maternal and infant outcomes during caesarean section."},{"source":"The information from the single trial in acute postoperative pain suggests it to be a useful analgesic, but at doses not very different from racemic ibuprofen.","target":"Output 1: The provided articles suggest that single doses of dexketoprofen trometamol and ibuprofen are effective in managing moderate to severe postoperative dental pain in adults and adolescents. The evidence is strong enough to conclude that dexibuprofen, as a single dose oral intervention, is an effective option for acute postoperative pain relief in adults based on the significant pain relief and superiority over placebo observed in multiple studies. However, more research may be needed to directly compare dexibuprofen to other NSAIDs, such as dexibuprofen, in larger and more diverse patient populations.\n\nOutput 2: The provided articles suggest that single dose intravenous flurbiprofen and ibuprofen lysine are effective in managing postoperative pain in children and adults, respectively. Etoricoxib, a cyclooxygenase-2 selective inhibitor, also shows promise in providing rapid and effective analgesia in adults. However, more studies are needed to evaluate the efficacy and safety of single dose oral dexibuprofen specifically for acute postoperative pain in adults. The evidence from the provided articles is strong for the use of intravenous flurbiprofen and ibuprofen lysine, but limited for oral dexibuprofen.\n\nOutput 3: Based on the provided articles, there is evidence suggesting that concurrent ibuprofen and paracetamol can provide better analgesic efficacy than either drug alone for acute postoperative dental pain in adults and adolescents. However, there is limited information directly related to the effectiveness of a single dose of oral dexibuprofen for acute postoperative pain in adults. More studies are needed to validate the effectiveness and assess the strength of evidence for this specific intervention."},{"source":"Augmentation therapy with alpha-1 antitrypsin cannot be recommended, in view of the lack of evidence of clinical benefit and the cost of treatment.","target":"Output 1: The evidence from the provided articles suggests that intravenous alpha-1 antitrypsin augmentation therapy may help slow down the loss of lung tissue in patients with alpha-1 antitrypsin deficiency and lung disease, as indicated by a trend towards reduced annual loss in CT scans. However, the evidence is not conclusive as some studies did not find a significant treatment effect on lung function or survival. More studies are needed to validate the effectiveness and long-term benefits of alpha-1 antitrypsin augmentation therapy in this patient population.\n\nOutput 2: The evidence from the provided articles suggests that intravenous alpha-1 antitrypsin augmentation therapy may have a protective effect against lung tissue loss in patients with alpha-1 antitrypsin deficiency and moderate emphysema, as shown by a trend towards a lower rate of loss in CT scans. However, the evidence is not yet strong enough to definitively conclude that the therapy is effective, as some studies did not find a significant difference in FEV1 decline between treatment and placebo groups. Larger trials with more patients are needed to confirm these findings and establish the efficacy of alpha-1 antitrypsin augmentation therapy for treating lung disease in patients with this deficiency.\n\nOutput 3: The evidence from the provided articles suggests that intravenous alpha-1 antitrypsin augmentation therapy may have a protective effect against lung tissue loss in patients with alpha-1 antitrypsin deficiency, as indicated by CT densitometry. However, the evidence is not yet strong enough to definitively conclude that this intervention significantly slows down the decline of FEV1 or improves clinical outcomes, as some studies showed no significant difference between treatment and placebo groups. Further trials with larger sample sizes are needed to confirm these findings and establish the clinical significance of alpha-1 antitrypsin augmentation therapy for treating lung disease in patients with this deficiency."},{"source":"Magnesium sulphate more than halves the risk of eclampsia, and probably reduces maternal death. There is no clear effect on outcome after discharge from hospital. A quarter of women report side effects with magnesium sulphate.","target":"Output 1: The evidence from multiple clinical trials suggests that magnesium sulphate is more effective than diazepam and phenytoin in preventing seizures in women with pre-eclampsia and eclampsia. Magnesium sulphate reduces the risk of recurrent convulsions by up to 67%, and there is no significant difference in maternal mortality or other measures of serious maternal morbidity or perinatal morbidity or mortality. The evidence is strong enough to justify the use of magnesium sulphate as the anticonvulsant of choice for women with pre-eclampsia to prevent seizures. However, more studies are needed to evaluate the long-term effects and potential side-effects of magnesium sulphate.\n\nOutput 2: The evidence from the Collaborative Eclampsia Trial and the Magpie Trial strongly supports the use of magnesium sulphate over diazepam and phenytoin for the prevention and treatment of eclampsia in women with pre-eclampsia. Magnesium sulphate reduces the risk of recurrent convulsions and maternal mortality, with no significant differences in other measures of serious maternal or neonatal morbidity or perinatal mortality. The results are consistent across different study designs and populations, providing compelling evidence for the effectiveness and safety of magnesium sulphate in this context.\n\nOutput 3: The evidence suggests that magnesium sulphate is effective in preventing eclamptic seizures in women with severe pre-eclampsia, reducing the risk by up to 67%. It is more effective than diazepam and phenytoin as an anticonvulsant. However, its impact on perinatal mortality is not clearly demonstrated. The evidence is strong enough to justify the use of magnesium sulphate as the anticonvulsant of choice in severe pre-eclampsia, but more studies may be needed to fully understand its benefits and risks."},{"source":"The evidence from this review suggests that there are no clinically meaningful BP lowering differences between available ARBs. The BP lowering effect of ARBs is modest and similar to ACE inhibitors as a class; the magnitude of average trough BP lowering for ARBs at maximum recommended doses and above is -8\/-5 mmHg.\u00a0 Furthermore, 60 to 70% of this trough BP lowering effect occurs with recommended starting doses. The review did not provide a good estimate of the incidence of harms associated with ARBs because of the short duration of the trials and the lack of reporting of adverse effects in many of the trials.","target":"Output 1: The articles provide evidence that angiotensin receptor blockers, such as irbesartan, losartan, and valsartan, effectively lower blood pressure in patients with primary hypertension. The studies show that higher doses of these medications result in greater reductions in blood pressure compared to lower doses. For instance, in one study, 300 mg irbesartan produced greater reductions in blood pressure than 100 mg losartan. The evidence is strong enough to conclude that angiotensin receptor blockers are effective in lowering blood pressure in primary hypertension, and higher doses result in greater reductions. However, more studies may be needed to determine the optimal dosing strategy and long-term effects of these medications.\n\nOutput 2: The articles provide evidence that angiotensin receptor blockers, such as valsartan, losartan, and tasosartan, effectively lower blood pressure in primary hypertension. The studies show significant reductions in both diastolic and systolic blood pressure with various dosages of these medications. The evidence is strong enough to conclude that angiotensin receptor blockers are an effective intervention for primary hypertension, with dosage-related efficacy. However, more studies may be needed to compare the efficacy and safety of different angiotensin receptor blockers directly and to assess long-term outcomes.\n\nOutput 3: The articles provide evidence that angiotensin receptor blockers (ARBs) effectively lower blood pressure in primary hypertension. The studies suggest an average blood pressure reduction of 5-10 mmHg with ARB monotherapy and additional significant reductions when combined with other antihypertensive agents. The evidence is strong, as multiple randomized controlled trials have consistently shown ARBs' blood pressure-lowering efficacy. However, individual responses may vary, and further studies may be needed to fully understand the dose-response relationship and potential long-term benefits."},{"source":"T-tube drainage appeared to result in significantly longer operating time and hospital stay compared with primary closure without any apparent evidence of benefit on clinically important outcomes after open common bile duct exploration. Based on the currently available evidence, there is no justification for the routine use of T-tube drainage after open common bile duct exploration in patients with common bile duct stones. T-tube drainage should not be used outside well designed randomised clinical trials. More randomised trials comparing the effects of T-tube drainage versus primary closure after open common bile duct exploration may be needed. Such trials should be conducted with low risk of bias and assessing the long-term beneficial and harmful effects of T-tube drainage, including long-term complications such as bile stricture and recurrence of common bile duct stones.","target":"Output 1: The evidence suggests that T-tube drainage of the common bile duct after exploration is a traditional practice following choledochotomy and stone removal. However, primary closure without external drainage has been shown to be feasible, safe, and cost-effective in some studies. These studies report lower incidences of postoperative bacteremia, mortality, and early morbidity with primary closure compared to T-tube drainage. However, some patients in the primary closure group still required T-tubes for drainage. The evidence is strong enough to suggest that primary closure is an effective alternative to T-tube drainage, but more studies may be needed to confirm these findings and to assess the long-term outcomes.\n\nOutput 2: The evidence from the provided articles suggests that primary closure of the common bile duct without T-tube drainage after laparoscopic choledochotomy is a safe and feasible alternative to traditional T-tube placement. Several randomized studies have shown no significant difference in postoperative complications, length of hospital stay, or long-term outcomes between primary closure and T-tube drainage groups. However, primary closure may require meticulous technique and careful assessment of ductal clearance to ensure successful closure. Overall, the evidence is strong enough to support the use of primary closure as a safe and effective alternative to T-tube drainage in select cases. However, more studies may be needed to validate the applicability of this approach in a wider range of patients and surgical settings.\n\nOutput 3: The evidence from the provided articles suggests that primary closure of the common bile duct without external drainage after open choledochotomy is a safe and cost-effective alternative to T-tube drainage. Several studies have shown that primary closure results in shorter operative times, postoperative stays, and hospital expenses, as well as lower incidences of overall and biliary complications. However, it is important to note that these studies had small sample sizes and further research is needed to confirm these findings on a larger scale. Overall, the evidence appears to support the use of primary closure as a viable alternative to T-tube drainage in open common bile duct exploration."},{"source":"Pacifier use in healthy term breastfeeding infants, started from birth or after lactation is established, did not significantly affect the prevalence or duration of exclusive and partial breastfeeding up to four months of age. However, evidence to assess the short-term breastfeeding difficulties faced by mothers and long-term effect of pacifiers on infants' health is lacking.","target":"Output 1: The evidence from the provided articles suggests that pacifier use does not significantly affect the duration or prevalence of breastfeeding in term infants. While some studies report a correlation between pacifier use and early weaning, others find no such association when controlling for confounding factors. Overall, the evidence is inconclusive and more studies are needed to definitively answer the question of whether pacifier use increases or decreases the duration of breastfeeding in term infants.\n\nOutput 2: The evidence from the provided articles suggests that pacifier use does not significantly decrease the prevalence or duration of breastfeeding in term infants. While some studies show that pacifiers can interfere with breastfeeding in observational studies, randomized controlled trials have not found a causal relationship between pacifier use and early weaning. Additionally, pacifiers can have benefits, such as reducing the risk of sudden infant death syndrome and providing comfort to infants during painful procedures. Overall, the evidence is not strong enough to definitively conclude that pacifier use increases or decreases the duration of breastfeeding in term infants, and more studies may be needed to fully understand the relationship between the two.\n\nOutput 3: The evidence from the provided articles suggests that pacifier use may be negatively associated with exclusive breastfeeding and early weaning, but the causality is unclear. One study found no significant difference in breastfeeding duration between infants offered and not offered pacifiers. Another study reported that pacifier use during gavage feeding accelerated sucking reflex maturation and facilitated oral feedings. However, the World Health Organization and UN Children's Fund discourage pacifier use due to potential interference with breastfeeding. Overall, more studies are needed to establish a definitive conclusion on the effect of pacifier use on breastfeeding duration in term infants."},{"source":"The studies included in this review do not allow firm conclusions as to the question of whether the quality of life of people after anterior resection is superior to that of people after abdominoperineal excision\/Hartmann's operation. The included studies challenges the assumption that anterior resection patients fare better.Larger, better designed and executed prospective studies are needed to answer this question.","target":"Output 1: The evidence suggests that patients undergoing rectal resection for cancer, with or without colostomy, experience varying degrees of quality of life (QOL) impacts. Some studies indicate better early QOL with coloanal anastomosis and sphincter preservation, while others report no significant difference in long-term QOL between colostomy and anterior resection groups. However, the evidence is not conclusive, and more studies are needed to validate these findings and determine the optimal treatment strategy for maintaining QOL after rectal resection for cancer.\n\nOutput 2: The evidence suggests that patients undergoing coloanal J-pouch anastomosis report better quality of life than those with abdominoperineal resection or low colorectal anastomosis without a pouch. However, temporary or permanent stoma formation can have significant adverse effects on subsequent health-related quality of life. The longitudinal impact of stoma formation on quality of life in rectal cancer patients undergoing adjuvant chemotherapy shows that stoma patients had similar or significantly improved symptom scores for fatigue, pain, GI problems, and sleep disturbance, but no such improvements were observed in patients without stomas. However, the impairment in social functioning persisted at one and three years after adjuvant chemotherapy. Overall, the evidence is strong enough to support the conclusion that coloanal J-pouch anastomosis leads to better quality of life than abdominoperineal resection or low colorectal anastomosis without a pouch, but the impact of stomas on quality of life should be carefully considered.\n\nOutput 3: The evidence suggests that the quality of life after rectal cancer surgery, with or without a colostomy, is not significantly different from that of the general population. However, patients with stomas may experience impairments in social functioning during adjuvant treatment and persistently thereafter. The choice between treatment options should consider preoperative function and the potential impact on quality of life beyond physical health. While some studies suggest that sphincter preservation may lead to better functional outcomes and quality of life, more research is needed to confirm this. Overall, the evidence is mixed and more studies are needed to provide a definitive conclusion."},{"source":"Cyproterone acetate combined with estradiol results in a subjective improvement in hirsutism compared to placebo. Clinical differences in outcome between cyproterone acetate and other medical therapies were not demonstrated in the studies included in this review. This may be because of the small size of the studies, lack of standardized assessment and lack of objective determinants of improvement in hirsutism. The endocrinological effects of the different drug therapies reflect the mode of action. Larger carefully designed studies are needed to compare efficacy and safety profiles between drug therapies for hirsutism.","target":"Output 1: The evidence from the provided articles suggests that cyproterone acetate is an effective treatment for hirsutism, as shown by decreases in hirsutism scores and androgen levels. However, the studies also indicate that other antiandrogens, such as flutamide and spironolactone, may also be effective alternatives. The evidence is strong but more studies are needed to compare the long-term efficacy and side effects of these different treatments. Overall, cyproterone acetate is a well-established option for hirsutism treatment, but individual responses may vary and other factors, such as cost and patient preferences, should be considered when making treatment decisions.\n\nOutput 2: The evidence from the provided articles suggests that cyproterone acetate is an effective treatment for hirsutism, with some studies reporting similar efficacy to other antiandrogens like flutamide and spironolactone. The results show decreases in hirsutism scoring and improvements in acne and seborrhea. However, the evidence is not definitive, as some studies have limitations such as small sample sizes and short durations. More research is needed to confirm the long-term efficacy and safety of cyproterone acetate in the treatment of hirsutism.\n\nOutput 3: The evidence from the provided articles suggests that cyproterone acetate is effective in reducing hirsutism symptoms, with an average decrease in hirsutism scores observed in all studies. However, some studies also indicate that other interventions such as spironolactone, finasteride, and metformin may also be effective. The evidence is generally strong, but more studies may be needed to compare the efficacy and safety of different interventions directly and to establish long-term outcomes. Overall, cyproterone acetate is a well-established treatment option for hirsutism, but individual responses may vary, and other factors such as the presence of other symptoms and the patient's BMI may influence the choice of treatment."},{"source":"When MV was introduced in the 1960s to treat infants with severe respiratory failure due to pulmonary disease, trials showed an overall reduction in mortality which was most marked in infants born with a birthweight of more than 2 kg. This review does not provide information to evaluate the relative benefits or harms of MV in the setting of modern perinatal care.","target":"Output 1: The articles provide evidence on different ventilation modalities for newborn infants with respiratory failure due to pulmonary disease, including high-frequency oscillatory ventilation (HFOV), volume controlled ventilation, and high-frequency jet ventilation (HFJV). The studies suggest that these interventions can improve oxygenation, reduce the need for surfactant administration, and decrease lung injury in some cases. However, the evidence is not entirely consistent, and some studies did not find significant differences between the interventions. Overall, the evidence is strong enough to suggest that these ventilation modalities can be effective in managing respiratory failure in newborn infants with pulmonary disease, but more studies are needed to determine which modality is most effective and safe in different clinical contexts.\n\nOutput 2: The evidence from the provided articles suggests that mechanical ventilation with specific ventilation settings, such as high rates and short inspiratory times, can reduce the risk of lung injury and improve outcomes in newborn infants with respiratory failure due to various pulmonary diseases. However, more studies are needed to validate these findings and determine the optimal ventilation strategies for different patient populations. Additionally, the use of surfactant replacement therapy and prone positioning have also been shown to improve outcomes in some cases. Overall, the evidence is strong enough to support the use of mechanical ventilation as a standard treatment for newborn infants with respiratory failure due to pulmonary disease, but further research is needed to optimize ventilation strategies and minimize complications.\n\nOutput 3: The evidence from the provided articles suggests that various interventions during mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease can improve outcomes. These interventions include muscle relaxation, early use of surfactant, high-frequency oscillatory ventilation, and inhaled nitric oxide. The studies show reductions in mortality, air leak syndrome, intraventricular hemorrhage, and bronchopulmonary dysplasia. However, more studies are needed to validate these findings and establish the optimal ventilation strategies for different types and severities of pulmonary diseases in newborn infants."},{"source":"The data available are inadequate to assess any potential benefit or harm that might result from hyperventilation in severe head injury. Randomised controlled trials to assess the effectiveness of hyperventilation therapy following severe head injury are needed.","target":"Output 1: The evidence from the provided article suggests that prophylactic hyperventilation is deleterious in head-injured patients with motor scores of 4-5. Biochemical data indicated that hyperventilation could not sustain alkalinization in the CSF, and cerebral blood flow was lower in the HV + THAM group than in the control and HV groups. However, mean ICP could be kept well below 25 mm Hg in all three groups, and the course of ICP was most stable in the HV + THAM group. Overall, the evidence is not strong enough to justify the conclusion that hyperventilation therapy is effective for acute traumatic brain injury, and more studies are needed to validate its use.\n\nOutput 2: The evidence regarding hyperventilation therapy for acute traumatic brain injury is controversial. While hyperventilation can lead to cerebral vasoconstriction and reversal of brain and CSF acidosis, there are concerns about its adverse effects, particularly prolonged hyperventilation. A randomized trial on the topic has not been conducted. The articles provided suggest that prophylactic hyperventilation is deleterious in head-injured patients with motor scores of 4-5, and that a combination of very early decompressive craniectomy and conventional medical management may be more effective in reducing intracranial hypertension and improving outcomes. However, more studies are needed to validate these findings and to determine the optimal approach to hyperventilation therapy in acute traumatic brain injury.\n\nOutput 3: The evidence from the provided articles suggests that prophylactic hyperventilation is deleterious in head-injured patients with motor scores of 4-5, as it is associated with a lower number of favorable outcomes at 3 and 6 months post-injury compared to control and HV + THAM groups. However, therapeutic mild hypothermia and hyperbaric oxygenation have shown promise in improving intracranial pressure and cerebral metabolism, respectively, in severe traumatic brain injury patients. More studies are needed to establish the optimal use and effectiveness of these interventions."},{"source":"Acupuncture appeared to be safe but without clear evidence of benefit. The number of patients is too small to be certain whether acupuncture is effective for treatment of acute ischaemic or haemorrhagic stroke. Larger, methodologically-sound trials are required.","target":"Output 1: The evidence from the provided articles suggests that acupuncture may have a positive effect on neurological outcome and daily life activities in acute stroke patients. However, the results are not consistent across all studies, and some do not show significant differences between acupuncture and control groups. The sample sizes in these studies are also relatively small. Therefore, more high-quality, large-scale clinical trials are needed to establish the average effectiveness and validity of acupuncture as a treatment for acute stroke.\n\nOutput 2: The evidence from the provided articles suggests that acupuncture may improve motor functions and activities of daily living in acute stroke patients. However, the overall effectiveness of acupuncture is not yet proven, as some studies report no significant benefits. The evidence is mixed, and more high-quality, large-scale trials are needed to establish the average effectiveness and validity of acupuncture as a treatment for acute stroke.\n\nOutput 3: The evidence regarding the effectiveness of acupuncture in acute stroke is inconclusive. Some studies suggest that acupuncture may improve motor functions and daily life activities, while others do not find significant benefits. The quality of the available evidence is moderate, and more well-designed trials are needed to establish the efficacy of acupuncture in this population."},{"source":"Chemotherapy is effective in prolonging time to disease progression and survival in patients with advanced colorectal cancer. The survival benefit may be underestimated by this meta-analysis, as a proportion of patients in the control arms of some trials received chemotherapy. No age related differences were found in the effectiveness of chemotherapy, but elderly patients were under represented in trials. Treatment toxicity and impact upon quality of life and symptom control have been inadequately assessed in the majority of trials and further research is needed to clarify the palliative benefit of chemotherapy.","target":"Output 1: The evidence from the provided articles suggests that palliative chemotherapy is an effective form of treatment for advanced or metastatic colorectal cancer. Several studies report objective responses and improved survival in patients receiving chemotherapy compared to expectant care or no treatment. The cost-effectiveness of palliative chemotherapy is also supported by some studies. However, more research is needed to fully understand the optimal chemotherapy regimens and the role of surgery in combination with chemotherapy for metastatic colorectal cancer.\n\nOutput 2: The evidence from the provided articles suggests that palliative chemotherapy can prolong survival and improve quality of life in advanced or metastatic colorectal cancer patients. The studies show significant survival benefits in certain patient groups, such as those with unresectable synchronous liver metastases or Dukes C rectal cancer. However, the economic cost-effectiveness of palliative chemotherapy is still unclear and requires further investigation. Overall, the evidence is strong enough to support the use of palliative chemotherapy as an effective treatment option for advanced or metastatic colorectal cancer, but more studies are needed to fully understand its benefits and limitations.\n\nOutput 3: The evidence from the provided articles suggests that palliative chemotherapy is an effective form of treatment for advanced or metastatic colorectal cancer, improving survival and quality of life. However, the specific regimens and combinations of chemotherapeutic agents vary, and the optimal approach remains unclear. The studies generally have small sample sizes and varying designs, limiting the strength of the evidence. Further randomized controlled trials are needed to validate the findings and determine the most effective and cost-effective chemotherapy regimens for this patient population."},{"source":"There was insufficient robust evidence from randomised trials to establish the relative effectiveness of different methods of anaesthesia, different associated physical techniques or the use of drug adjuncts in the treatment of distal radial fractures. There is, however, some indication that haematoma block provides poorer analgesia than IVRA, and can compromise reduction.\nGiven the many unresolved questions over the management of these fractures, we suggest an integrated programme of research, which includes consideration of anaesthesia options, is the way forward.","target":"Output 1: The evidence from the provided articles suggests that haematoma blocks with sedation and external fixation are effective alternatives to general anaesthesia for treating distal radial fractures in adults. Haematoma blocks with sedation provide better patient acceptance and are more efficient in terms of time and resources. External fixation maintains accurate anatomic position until solid fracture healing is achieved. However, more studies are needed to validate these conclusions as the sample sizes in the studies were relatively small and there was variability in the results. Additionally, the studies did not directly compare the pain perception and post-manipulation pain between the different anaesthetic techniques in a head-to-head manner.\n\nOutput 2: Several studies have investigated different anesthesia techniques for treating distal radial fractures in adults, including Bier's block, external fixation with sedation, Norian SRS, and functional treatment. The evidence suggests that various anesthesia methods can effectively manage pain and facilitate manipulation during reduction and fixation. However, the optimal approach may depend on the specific fracture type and patient factors. The evidence is generally strong, but more studies are needed to compare the long-term outcomes and costs of different interventions. Overall, the evidence supports the use of regional anesthesia techniques, such as Bier's block and spinal anesthesia, as effective and cost-efficient options for treating distal radial fractures in adults.\n\nOutput 3: The studies suggest that haematoma blocks with sedation or general anaesthesia have similar radiological correction for distal radial fractures in adults. However, haematoma blocks alone may result in greater pain during manipulation, while post-manipulation pain is greater with general anaesthesia. Waiting and manipulation times, as well as resource costs, are greater with general anaesthesia. No complications were reported for any anaesthetic method. Patient acceptance is greater with correctly performed haematoma blocks and sedation. The evidence is strong enough to support the use of haematoma blocks with sedation as an effective and efficient alternative to general anaesthesia for treating distal radial fractures in adults."},{"source":"Cytisine increases the chances of quitting, although absolute quit rates were modest in two recent trials. Varenicline at standard dose increased the chances of successful long-term smoking cessation between two- and threefold compared with pharmacologically unassisted quit attempts. Lower dose regimens also conferred benefits for cessation, while reducing the incidence of adverse events. More participants quit successfully with varenicline than with bupropion. Two open-label trials of varenicline versus NRT suggested a modest benefit of varenicline but confidence intervals did not rule out equivalence. Limited evidence suggests that varenicline may have a role to play in relapse prevention. The main adverse effect of varenicline is nausea, but mostly at mild to moderate levels and tending to subside over time. Possible links with serious adverse events, including serious psychiatric or cardiovascular events, cannot be ruled out.\n\nFuture trials of cytisine may test extended regimens and more intensive behavioural support. There is a need for further trials of the efficacy of varenicline treatment extended beyond 12 weeks.","target":"Output 1: The articles provide evidence for the effectiveness of nicotine receptor partial agonists, specifically varenicline and mecamylamine, in promoting smoking cessation. The studies suggest that these medications increase abstinence rates and reduce cravings compared to placebo. However, side effects and relapse risks are common concerns. The evidence is strong enough to support the use of nicotine receptor partial agonists as a smoking cessation intervention, but more studies are needed to evaluate long-term efficacy and safety. Additionally, combination therapies, such as nicotine replacement therapy and behavioral interventions, may enhance the effectiveness of these medications.\n\nOutput 2: The articles provide evidence for the effectiveness of nicotine receptor partial agonists, specifically varenicline, in smoking cessation. The average effectiveness is shown in several studies to double or nearly double the smoking cessation rate compared to placebo. The evidence is strong, as multiple randomized controlled trials have been conducted with significant results. However, more studies may be needed to evaluate the role of other partial agonists and to assess long-term abstinence rates.\n\nOutput 3: The articles provide evidence for the effectiveness of nicotine receptor partial agonists, specifically varenicline and dianicline, in smoking cessation. The studies show that these drugs increase abstinence rates compared to placebo and reduce craving and nicotine withdrawal symptoms. The evidence is strong enough to support the conclusion that nicotine receptor partial agonists are effective smoking cessation interventions. However, more studies are needed to determine the optimal dosing and personalization of these treatments based on factors such as nicotine dependence and genotype."},{"source":"The use of ddI and, to a lesser extent, ddC delayed both HIV disease progression and death, at least when added to AZT.","target":"Output 1: The evidence from the provided articles suggests that combination therapy with zidovudine and either didanosine or zalcitabine may be more effective than zidovudine monotherapy in HIV-infected adults with little or no previous zidovudine treatment. However, the trials did not find significant differences in disease progression or survival between the combination therapies and zidovudine alone in advanced HIV infection. The evidence is strong enough to support the use of combination therapy in certain patient populations, but more studies may be needed to fully understand the benefits and risks in different contexts.\n\nOutput 2: The Delta trial compared zidovudine (AZT) alone to AZT plus didanosine (ddI) or zalcitabine (ddC) in HIV-infected individuals. The study did not find that combinations were superior to AZT alone in extending survival or delaying disease progression. The evidence is not strong enough to justify a definitive conclusion about the average effectiveness of AZT versus AZT plus ddI versus AZT plus ddC in HIV infected adults. More studies are needed to validate the findings.\n\nOutput 3: The Delta trial compared Zidovudine (AZT) alone to AZT plus didanosine (ddI) or zalcitabine (ddC) in HIV-infected individuals. Both AZT plus ddI and AZT plus ddC significantly improved survival and delayed disease progression compared to AZT alone in participants who had not previously taken AZT. The addition of ddl improved survival in those previously treated with AZT, but the benefit was less. The overall difference in survival between the treatment groups was significant. The evidence is strong enough to justify the conclusion that combination therapy with AZT and either didanosine or zalcitabine is more effective than monotherapy in extending survival and delaying disease progression in HIV-infected adults."},{"source":"Researchers sometimes adopt attention check questions that ask participants to think back to an earlier part of the survey and recall specific information. Read the 'Generated Summaries' section, and follow the instructions exactly.","target":"Select the order for Outputs B, A, C as the following: 3, 2, 1"},{"source":"Only tentative conclusions can be drawn from the available evidence in this review. Compared with ORIF, there was some evidence that radial head replacement had better elbow function and fewer adverse events for Mason type III radial head fractures in the short term. However, the evidence is of low quality and it is unknown whether these results would apply in the longer term or more generally. Using biodegradable implants may be as good as metallic implants for fixation of some usually more stable fractures but more evidence is needed to confirm this. There is a need for good quality evidence for addressing the areas of uncertainty for the surgical treatment of radial head fractures.","target":"Output 1: The evidence from the provided articles suggests that bipolar radial head prosthesis replacement is more effective than open reduction and internal fixation (ORIF) in treating Mason type III radial head fractures, as indicated by better clinical results and lower complication rates (P = 0.0004). However, more studies are needed to validate this conclusion for other types of radial head fractures in adults. The use of biodegradable polylactide pins has at least comparable outcomes as standard metal implants for the internal fixation of displaced radial head fractures. Early mobilization in a sling is not significantly different from other treatment methods in terms of clinical outcomes. The choice between ORIF and prosthesis replacement depends on the specific fracture type and individual patient factors.\n\nOutput 2: The evidence from the provided articles suggests that the choice of treatment for radial head fractures in adults depends on the fracture type and stability. For stable, Mason type 1 and 2 fractures, early mobilization in a sling or immobilization in extension is recommended over immobilization in flexion due to better functional outcomes and fewer complications. For unstable, multi-fragmented fractures, radial head replacement with a metal prosthesis is more effective than open reduction and internal fixation in terms of clinical results and complication rate. Biodegradable implants have at least comparable outcomes as standard metal implants for the internal fixation of displaced radial head fractures. However, more studies are needed to validate these conclusions and to compare the effectiveness and safety of other surgical interventions for treating radial head fractures in adults, such as arthrodesis or arthroplasty.\n\nOutput 3: The evidence from the provided articles suggests that surgical interventions, such as open reduction and internal fixation (ORIF) and radial head replacement with prostheses, are effective in treating radial head fractures in adults, particularly for unstable and multi-fragmented fractures. The studies generally report better clinical outcomes and fewer complications with radial head replacement compared to ORIF. However, more studies are needed to confirm these findings and to evaluate the effectiveness of other interventions, such as biodegradable implants and external fixation, in treating radial head fractures in adults."},{"source":"Researchers sometimes adopt attention check questions that ask participants to think back to an earlier part of the survey and recall specific information. Read the 'Generated Summaries' section, and follow the instructions exactly.","target":"Select the order for Outputs B, A, C as the following: 3, 2, 1"},{"source":"There is no certain study regarding appropriate use, dose and length of therapy for acute GvHD. Further studies are needed to define the appropriate use of steroids and whether other agents are appropriate as frontline therapy.","target":"Output 1: The evidence suggests that corticosteroids, particularly methylprednisolone, reduce the incidence of acute GVHD without causing untoward effects when added to the combination of cyclosporine and methotrexate. However, the optimal timing of corticosteroid administration may be important for efficacy. The addition of antithymocyte globulin (ATG) to a regimen of high-dose cyclophosphamide has not significantly improved the outcome of allogeneic bone marrow transplantation for severe aplastic anemia. The results of allogeneic BMT for SAA have improved over time, and further studies are needed to determine the role of corticosteroids in the prevention and treatment of chronic GVHD. Overall, the evidence is strong enough to support the use of corticosteroids in the prevention and treatment of acute GVHD, but more studies are needed to fully understand their role in chronic GVHD and to determine the optimal dosing and timing.\n\nOutput 2: The evidence suggests that methotrexate\/cyclosporine is effective in decreasing the incidence of acute and chronic GVHD in HLA-identical marrow transplant recipients. The addition of prednisone to this regimen does not provide additional benefits. Corticosteroids, specifically methylprednisolone, are used in the initial treatment of acute GVHD, but the optimal tapering regimen is unclear. Passive immunotherapy with intravenous immunoglobulin decreases the risk of acute GVHD and infections. However, the minimally effective dose and long-term complications have not been established. Overall, more studies are needed to validate the optimal use of corticosteroids and other interventions for the treatment and prevention of acute and chronic GVHD after allogeneic stem cell transplantation.\n\nOutput 3: The evidence from the provided articles suggests that corticosteroids, specifically prednisone, can be effective in treating both acute and chronic GvHD after allogenic stem cell transplantation. However, the optimal dosing and timing of corticosteroid administration remain unclear. The addition of other drugs such as methotrexate, cyclosporine, and anti-T-cell globulins can improve GvHD prophylaxis and reduce the incidence of acute and chronic GvHD. However, the optimal combination and sequencing of these drugs are still being investigated. Overall, the evidence is strong enough to support the use of corticosteroids and other immunosuppressive agents in the treatment of GvHD, but more studies are needed to optimize their use and minimize side effects."},{"source":"There was one small cross-over study that was included in this review. There is insufficient evidence to recommend either method of gavage feeding. A randomised trial is needed to evaluate the benefits and harms of push versus gravity bolus tube feeding in preterm infants. Infants should be stratified by gestational age at birth (above and below 32 weeks) or birth weight (above and below 1500 grams) and respiratory support (ventilated versus non-ventilated) and the sample size should be of sufficient size to evaluate the primary outcomes outlined in this review (time to establish full tube feeds and feeding intolerance).","target":"Output 1: The evidence from the provided articles suggests that gravity intermittent bolus gavage feeding is more effective than continuous gastric infusion in improving feeding tolerance in small very low birth weight infants (FEEDING STRATEGIES FOR PREMATURER INFANTS: RANDOMIZED TRIAL OF GASTROINTESTINAL PRIMING AND TUBE-FEEDING METHOD). However, for premature and low birth weight infants, the choice between push and gravity for intermittent bolus gavage tube feeding is not directly addressed in the available studies. More research is needed to determine the specific effects of push versus gravity techniques on feeding tolerance and effectiveness in this population.\n\nOutput 2: The provided articles do not directly address the query regarding the effectiveness of push versus gravity for intermittent bolus gavage tube feeding in premature and low birth weight infants. However, they do suggest that intermittent gavage feedings are as efficacious as transpyloric feedings in providing nutrition to low birth weight infants, and that continuous nasogastric infusion may be better tolerated than intermittent bolus tube-feeding in very low birth weight infants. The evidence in these articles is strong enough to support these conclusions, but more studies are needed to specifically investigate the effects of push versus gravity during intermittent bolus gavage tube feeding.\n\nOutput 3: The evidence from the provided articles suggests that both intermittent bolus gavage tube feeding with gravity and push techniques are effective methods for feeding premature and low birth weight infants. However, the articles do not directly compare the average effectiveness of these two methods. The evidence is not strong enough to definitively conclude which method is superior, as some studies suggest that gravity may be more effective in reducing feeding intolerance, while others indicate that push techniques may lead to faster feeding advancement. Further studies are needed to provide more conclusive evidence on this topic."},{"source":"There is evidence for significant beneficial effects of regular exercise on physical fitness, walking capacity, cardiovascular dimensions (e.g. blood pressure and heart rate), health-related quality of life and some nutritional parameters in adults with CKD. Other outcomes had insufficient evidence due to the lack of data from RCTs. The design of the exercise intervention causes difference in effect size and should be considered when prescribing exercise with the aim of affecting a certain outcome. Future RCTs should focus more on the effects of resistance training interventions or mixed cardiovascular- and resistance training as these exercise types have not been studied as much as cardiovascular exercise.","target":"Output 1: The evidence from the provided articles suggests that exercise training, including aerobic and resistance training, can improve functional capacity and reduce inflammation in adults with chronic kidney disease. However, the studies have small sample sizes and varying outcomes, indicating that more research is needed to establish the optimal exercise intervention and its long-term effects on disease progression and outcomes. The evidence is moderate in strength, as the studies demonstrate improvements in functional measures and inflammatory markers, but larger trials are necessary to confirm these findings and determine the clinical significance.\n\nOutput 2: The evidence suggests that exercise training, particularly moderate- to high-intensity strength training, improves physical performance, nutritional status, and quality of life in adults with chronic kidney disease and on dialysis. Studies have also shown that resistance training can reduce inflammation and improve nutritional status in individuals with moderate kidney disease. However, more research is needed to determine if resistance training can improve disease outcomes long term. Exercise training programs have beneficial effects on end-stage renal disease patients on hemodialysis, but adherence rates are high. Exercise training during dialysis sessions may enhance dialysis efficacy and improve work performance and quality of life. Overall, the evidence is strong enough to support the use of exercise training as a beneficial intervention for adults with chronic kidney disease.\n\nOutput 3: The evidence suggests that exercise training, particularly moderate- to high-intensity strength training, improves physical performance, nutritional status, and quality of life in adults with chronic kidney disease, including those not on dialysis therapy. However, the effect of low-intensity strength training is less clear. One study showed that resistance training reduced inflammation and improved nutritional status in individuals with moderate chronic kidney disease consuming a low-protein diet. More studies are needed to determine the long-term effects of resistance training on disease outcomes. Exercise training is also feasible and may have clinical benefits for obese diabetic patients with chronic kidney disease. A large-scale randomized controlled trial is planned to investigate the effects of exercise on renal functions, cardiovascular fitness, inflammation, and oxidative stress in this population."},{"source":"There is insufficient evidence from randomised trials to determine whether surgery or conservative management was best for ACL injury in the 1980s, and no evidence to inform current practice. Good quality randomised trials are required to remedy this situation.","target":"Output 1: The evidence from the provided articles suggests that arthroscopic reconstruction using various graft types, such as bone-patellar tendon-bone, semitendinosus tendon, hamstring tendons, and patellar tendon, results in good clinical outcomes for adults with anterior cruciate ligament ruptures. However, some studies indicate that double-bundle reconstruction may provide better intraoperative stabilities than single-bundle reconstruction, but the clinical outcomes and postoperative stabilities are similar after a minimum of 2 years of follow-up. Overall, the evidence is strong enough to support the effectiveness of operative treatment for anterior cruciate ligament ruptures in adults, but more studies may be needed to compare the long-term outcomes and graft types directly.\n\nOutput 2: The evidence from the provided articles suggests that both operative and conservative treatments have good outcomes for anterior cruciate ligament ruptures in adults. However, the pivot-shift test was more often positive after conservative treatment, and operative treatment may provide better long-term stability and fewer recurrent sprains. The choice between the two treatments depends on the individual patient's preferences, instability level, and activity level. The evidence is strong enough to support the conclusion that both treatments are effective, but more studies are needed to determine which treatment is superior in the long term and for specific patient populations.\n\nOutput 3: The evidence from the provided articles suggests that arthroscopic reconstruction using either bone-patellar tendon-bone or hamstring tendon grafts is effective in treating anterior cruciate ligament ruptures in adults. However, the choice between the two graft types remains a matter of debate. Double-bundle reconstruction has been shown to produce better intraoperative stabilities but clinical outcomes and postoperative stabilities are similar to single-bundle reconstruction after a minimum of 2 years of follow-up. The use of drains after surgery does not seem to provide any benefit. Overall, the evidence is strong enough to support the effectiveness of operative treatment for anterior cruciate ligament ruptures in adults, but more studies are needed to determine which graft type is superior."},{"source":"Patients with Parkinson's disease who receive treadmill training are more likely to improve their impaired gait hypokinesia. However, the results must be interpreted with caution because there were variations between the trials in patient characteristics, the duration and amount of training, and types of treatment. Additionally, it is not known how long these improvements may last.","target":"Output 1: The evidence from the provided articles suggests that treadmill training, particularly with body weight support, can improve mobility, reduce postural instability, and increase fear of falling in patients with Parkinson's disease. These improvements have been shown to lead to better performance in activities of daily living and ambulation. However, more studies are needed to determine the long-term effects of treadmill training and to compare it to other interventions. Overall, the evidence is strong enough to support the use of treadmill training as a beneficial intervention for patients with Parkinson's disease, but further research is necessary to fully understand its impact.\n\nOutput 2: The evidence from the provided articles suggests that treadmill training with body weight support is effective in improving mobility, reducing postural instability and fear of falling in patients with Parkinson's disease. The studies show significant improvements in gait, balance, and functional tasks of lower extremities. However, more research is needed to determine the long-term benefits and optimal training protocols for this intervention. Overall, the evidence is strong enough to support the use of treadmill training as a valuable intervention for patients with Parkinson's disease.\n\nOutput 3: The evidence from the provided articles suggests that treadmill training, including body weight-supported and speed-dependent training, can improve mobility, reduce postural instability, and fear of falling in patients with Parkinson's disease. The studies show significant improvements in gait speed, stride length, balance, and functional tasks. The evidence is strong enough to support the conclusion that treadmill training is an effective intervention for patients with Parkinson's disease, but more studies are needed to determine the long-term effects and optimal training protocols."},{"source":"The evidence from the limited number of studies suggests that psychological and educational interventions may result in increased abstinence from alcohol, and a reduction in alcohol consumption among pregnant women. However, results were not consistent, and the paucity of studies, the number of total participants, the high risk of bias of some of the studies, and the complexity of interventions limits our ability to determine the type of intervention which would be most effective in increasing abstinence from, or reducing the consumption of, alcohol among pregnant women.","target":"Output 1: The evidence from the provided articles suggests that psychological and educational interventions, such as motivational interviewing, self-help programs, and brief counseling sessions, can effectively reduce prenatal alcohol consumption in pregnant women and women planning pregnancy. The studies report significant reductions in alcohol consumption and quit rates among intervention groups compared to control groups. The strongest effects were observed for light drinkers, African-Americans, and non-Protestants. However, more studies are needed to validate these findings and assess the long-term effectiveness of these interventions. Overall, the evidence is strong enough to support the use of these interventions as a promising approach to reducing prenatal alcohol consumption and improving pregnancy outcomes.\n\nOutput 2: The articles provide evidence for the effectiveness of psychological and educational interventions in reducing prenatal alcohol consumption among pregnant women and those planning pregnancy. The interventions include motivational interviewing, brief counseling, and home visitation programs. The studies show significant reductions in alcohol consumption and improved newborn outcomes, such as higher birthweights and lengths, and lower fetal mortality rates. The evidence is strong enough to support the conclusion that these interventions can be effective in reducing prenatal alcohol exposure. However, more studies are needed to validate the findings and to investigate the long-term effects of these interventions.\n\nOutput 3: The evidence suggests that motivational interventions, such as brief motivational interviews, show promise in reducing prenatal alcohol consumption among pregnant women and those planning pregnancy. These interventions have been shown to result in modest reductions in frequency of alcohol consumption in various populations. However, more studies are needed to validate these findings and to explore the long-term effectiveness of these interventions. The evidence is strong enough to justify the implementation of motivational interventions as a component of prenatal care, but further research is necessary to optimize their impact and reach."},{"source":"The findings of this review suggest that oral naltrexone did not perform better than treatment with placebo or no pharmacological agent with respect to the number of participants re-incarcerated during the study period. If oral naltrexone is compared with other pharmacological treatments such as benzodiazepine and buprenorphine, no statistically significant difference was found. The percentage of people retained in treatment in the included studies is however low (28%). The conclusion of this review is that the studies conducted have not allowed an adequate evaluation of oral naltrexone treatment in the field of opioid dependence. Consequently, maintenance therapy with naltrexone cannot yet be considered a treatment which has been scientifically proved to be superior to other kinds of treatment.","target":"Output 1: The evidence from the provided articles suggests that naltrexone maintenance treatment for opioid dependence shows promising results, with better retention rates and improved compliance compared to oral antagonists. However, some studies did not find significant differences between naltrexone and placebo groups in terms of treatment acceptance, retention rates, or opioid consumption. More studies are needed to validate the overall effectiveness of naltrexone maintenance treatment and to identify the specific population that may benefit the most from this intervention.\n\nOutput 2: The evidence from the provided articles suggests that naltrexone maintenance treatment can be effective in reducing opioid use and improving retention in rehabilitative programs for opioid-dependent individuals. However, poor compliance with naltrexone has been a challenge. The studies show moderate to significant reductions in opioid use and hospital presentations for overdose. However, more studies are needed to validate the long-term effectiveness and to address the issue of poor compliance. Overall, the evidence is promising but not yet conclusive.\n\nOutput 3: The evidence from the provided articles suggests that naltrexone maintenance treatment for opioid dependence shows promising results, with better retention index and improved compliance compared to oral antagonists. However, the studies have varying sample sizes and durations, and some did not find significant differences between naltrexone and placebo groups in terms of treatment acceptance, retention rates, or opioid consumption. Therefore, more studies with larger sample sizes and longer follow-up periods are needed to validate the average effectiveness of naltrexone maintenance treatment for opioid dependence."},{"source":"A significant health disparity exists, whereby Indigenous populations, a minority, are over-represented in the burden of smoking-related morbidity and mortality. This review highlights the paucity of evidence available to evaluate the effectiveness of smoking cessation interventions, despite the known success of these interventions in non-Indigenous populations. Due to this lack of published investigations, the external validity of this review is limited, as is the ability to draw reliable conclusions from the results. The limited but available evidence reported does indicate that smoking cessation interventions specifically targeted at Indigenous populations can produce smoking abstinence. However this evidence base is not strong with a small number of methodologically sound trials investigating these interventions. More rigorous trials are now required to assist in bridging the gap between tobacco related health disparities in Indigenous and non-Indigenous populations.","target":"Output 1: The articles provide evidence of various smoking cessation interventions among Indigenous populations, including the use of free nicotine patches, culturally tailored programs for Chinese Americans and Hispanics, community-based interventions in the Netherlands, incentive-based interventions, and internet-assisted interventions in schools. The results show modest to significant increases in smoking cessation rates compared to control groups, but the long-term effectiveness and generalizability of these interventions vary. The evidence is strong enough to suggest that culturally tailored interventions and the use of nicotine replacement therapy can be effective in certain populations, but more studies are needed to validate these findings and to explore the most effective strategies for smoking cessation in Indigenous populations.\n\nOutput 2: The articles provide evidence of various smoking cessation interventions for Indigenous populations, including culturally specific programs, web-based interventions, and physician-based interventions. The results suggest that these interventions have shown some effectiveness in increasing quit rates and reducing smoking consumption. However, the evidence is not consistently strong across all studies, and more research is needed to validate the average effectiveness of these interventions in Indigenous populations. Some studies have identified important factors, such as higher-depth tailoring and community involvement, that may enhance the effectiveness of smoking cessation programs. Overall, the evidence supports the need for continued research and the development of culturally appropriate and effective smoking cessation interventions for Indigenous populations.\n\nOutput 3: The evidence suggests that smoking cessation interventions, including the use of nicotine patches and culturally specific programs, have shown effectiveness in Indigenous populations. However, more studies are needed to validate the long-term benefits and to explore culturally appropriate behavioral interventions and clinical trials to increase smoking cessation and reduce exposure to smokeless tobacco. The evidence presented in the articles is strong in demonstrating the short-term effectiveness of these interventions, but further research is required to establish their long-term impact."},{"source":"From the available evidence we cannot determine whether or not preoperative analgesics are of benefit in paediatric dentistry for procedures under local anaesthetic. There is probably a benefit in prescribing preoperative analgesics prior to orthodontic separator placement.","target":"Output 1: The evidence suggests that preoperative administration of acetaminophen and ibuprofen may reduce postoperative pain in children undergoing dental procedures, but the results are not statistically significant in some studies. The use of patient-controlled analgesia (PCA) and the combination of caudal analgesia and rectally administered diclofenac have shown promise in reducing the need for subsequent analgesia. Etoricoxib, a new cyclooxygenase-2-selective inhibitor, has demonstrated rapid onset and long-lasting pain relief for acute pain, including dental surgery. However, more studies are needed to validate the effectiveness and safety of these interventions in children and adolescents having dental treatment.\n\nOutput 2: The evidence from the provided articles suggests that preoperative administration of acetaminophen, ibuprofen, and diclofenac may provide some pain relief in children and adolescents undergoing dental procedures. However, the results are not consistent, and the sample sizes are often small. The studies using more reliable pain assessment methods and larger sample sizes indicate a trend toward reduced postoperative pain in the pretreated groups. However, more studies are needed to definitively establish the efficacy and optimal dosing of preoperative analgesics for dental procedures in children and adolescents.\n\nOutput 3: The evidence from the provided articles suggests that preoperative administration of various analgesics, such as acetaminophen, ibuprofen, and paracetamol, can effectively reduce postoperative pain and the need for additional analgesics in children and adolescents undergoing dental procedures. The studies show significant improvements in pain relief and anxiety reduction, leading to faster rehabilitation. However, more studies with larger sample sizes and reliable pain assessment methods are needed to further validate these findings and determine the optimal analgesic regimen for different age groups and dental procedures."},{"source":"The results of this systematic review do not provide strong evidence for either the benefits or harms of early oxygen weaning in preterm\/LBW infants. Future research should be directed toward addressing the question of what are the most appropriate target levels of oxygenation, in both the early and late neonatal periods, rather than whether oxygen should be weaned early or late.","target":"Output 1: The provided articles do not directly address the query of early versus late discontinuation of oxygen in preterm or low birth weight infants. However, one article suggests that prone positioning may stabilize oxygenation for ventilated preterm infants, potentially conserving energy and decreasing complications of hypoxia (Decreased activity and oxygen desaturation in prone ventilated preterm infants during the first postnatal week). Another article investigates the effect of postnatal triiodothyronine replacement on the course of respiratory distress syndrome in preterm infants, suggesting a potential beneficial effect on oxygenation (Postnatal triiodothyronine replacement and respiratory distress syndrome of the preterm infant). Overall, more studies are needed to provide strong evidence on the effectiveness and optimal timing of oxygen discontinuation in preterm or low birth weight infants.\n\nOutput 2: The articles suggest that early versus late discontinuation of oxygen in preterm or low birth weight infants is an area of ongoing research. Some studies indicate that early discontinuation of oxygen may reduce the incidence of bronchopulmonary dysplasia and mortality, while others suggest that late discontinuation may be more beneficial in reducing the risk of brain injury. However, the evidence is not conclusive, and more studies are needed to validate these findings and determine the optimal timing for oxygen discontinuation in preterm or low birth weight infants. The studies also highlight the importance of considering individual infant characteristics, such as birth weight and gestational age, when making decisions about oxygen therapy.\n\nOutput 3: The provided articles suggest that preterm or low birth weight infants receiving IPPV with fractional concentration of inspired oxygen of 0.21 had a shorter course to reach this level with IPPV compared to HFOV (9.3+\/-4.5 days vs 27.5+\/-10.2 days, p = 0.01). Early oxygen therapy, such as SSC with mothers, maintains higher oxygen saturation and reduces desaturation in low-birth-weight infants. However, post hoc analyses indicate that infants with a birth weight of 1000 g or less who are treated with inhaled nitric oxide have higher mortality and increased rates of severe intracranial hemorrhage. More studies are needed to determine the optimal timing of oxygen discontinuation in preterm or low birth weight infants and its impact on long-term outcomes."}]